MANHATTAN, Kan., Nov. 21, 2019 /PRNewswire/ — Libella Gene Therapeutics, LLC (“Libella”) announces an institutional review board (IRB)-approved pay-to-play clinical trial in Colombia ( South America ) using gene therapy that aims to treat and ultimately cure aging. This could lead to Libella offering the world’s only treatment to cure and reverse aging by 20 years.
A team of scientists at the University of Antwerp (Belgium) wants to stop the aging process. They are fascinated by uncovering longevity signatures at the tiny molecular level and are developing an intelligent nanomachine that lays the foundations for new therapies against aging and chronic diseases. Only ten conditions cause 75% of all mortalities. The top three of cardiovascular disease, diabetes, and cancer accounts for 50% of all mortalities. Are these chronic diseases age-related? Can we address them by targeting aging?
Chemotherapy-treated cancer cells that enter a non-dividing state called senescence can nevertheless boost cancer growth. The finding that these cells eat neighbouring cells reveals a mechanism that enables senescent cells to persist. Chemotherapy-treated tumours boost their survival by ingesting cells.
Give the gift of cutting edge longevity insight with our Black Friday sale: $20 off 2019 RAADfest video collection starting now! 🔛https://vimeo.com/ondemand/raadfest2019
Increases in life span are one of the greatest success stories of modern society. Yet, while most of us can expect to live longer, we are spending more years in ill health. Reducing this period of ill health at the end of life is the main aim of a group of scientists known as biogerontologists.
By studying aging in animals, including fruit flies, worms, and rodents, biogerontologists have identified biological phenomena involved with aging that all these organisms share. And some of these biological processes may also regulate aging in humans.
Scientists attempting to understand and improve the aging process have identified many molecules that appear to improve aging in these animals (although evidence in humans remains scant). These molecules include compounds found in grapes, apples, and even bacteria.
Husbands Ian and Leon discuss the future of longevity technology and genetic research in Silicon Valley with the infamous bio-tech renegade Aubrey DeGrey.
Ian and Leon then drive a classic car down the Pacific Coast Highway and into the desert to the 7th Day Adventist community of Loma Linda to learn about “Blue Zones” and how anyone can make simple lifestyle changes that would allow them to live radically longer lives.
We will have a fresh new presentation on Exosomes “The End of Aging” by Harvard Genetics Genius Dr. Duncan Ross, the Founder of Kimera Labs. And Bill Faloon will present the latest in Age Reversal research.
Visit The Church of Perpetual Life this Thursday, November 21st at 7:00 PM. Our Doors open at 6:00 PM Before the service: Enjoy tasty snacks, networking and conversations on Age Reversal, Cryonics, The Singularity and other topics of interest to all for the quest of an Unlimited Life. Stay afterwards as we have a delicious 5 star dinner reception with speakers.
Bring a friend! Someone that you would like to share news of amazing emerging technologies on Health & Extreme Longevity!
“Our task is to make nature, the blind force of nature, into an instrument of universal resuscitation and to become a union of immortal beings.“ - Nikolai F. Fedorov
We hold faith in the technologies & discoveries of humanity to END AGING and Defeat involuntary Death within our lifetime.
Working to Save Lives with Age Reversal Education.
A particularly harmful byproduct of oxidized cholesterol appears to be a primary cause of atherosclerosis and a therapeutic target ripe for the taking. A new review takes a look at 7-ketocholesterol and its role in aging and disease.
A new review exploring 7-ketocholesterol
We recently reported on the launch of Underdog Pharma, a new startup biotech company that was spun off from many years of research at SENS Research Foundation and is focused on the problem of 7-ketocholesterol.